Mamantia, Rejane .

HRN: 23-58-04  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2023
CEFTAZIDIME 1GM (VIAL)
10/06/2023
10/12/2023
IVT
50mg
Q6
Pcap C
Waiting Final Action 
10/09/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/09/2023
10/15/2023
IV
25mg
OD
Neonatal Pneuumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: